Results: Eighteen interviews were conducted with 23 staff across 11 ACCHS. Quantitative data found staff were confident in providing iECG screening and managing the referral pathway, and thought the process was beneficial for patients. Qualitative data highlighted the usefulness of the device to undertake opportunistic screening and acceptability in routine practice, and provided opportunities to engage patients in education around AF.
1
Cardiovascular disease is the main cause of mortality among Aboriginal and Torres Strait Islander people in Australia (hereafter Aboriginal people). 2 Handheld electrocardiogram (ECG) devices have been recommended internationally as preferred screening tools for the diagnosis of atrial fibrillation. 3 These devices can attach to mobile phones, are typically referred to as iECG and have demonstrated effectiveness and acceptability in clinical and community settings such as dental vans, pharmacies 4 and in general practice. 5, 6 Both systematic and opportunistic screening of adults for AF increased the detection rate of new cases compared with routine practice and opportunistic screening has greater cost-effectiveness than systematic screening. 7 Competence and confidence of nurses facilitated iECG screening whereas a lack of staff availability and technical issues obstructed screening. 6 A recent study found the majority of iECG-screened participants were satisfied with the device, finding it easy to use without restricting activities or causing anxiety. 8 A scoping review on AF in Indigenous populations internationally found higher AF hospitalisation rates relative to other populations and occurrence at younger ages and with more comorbidity. 9 National data reports the AF rate, as either a principal or additional diagnosis, was 1.4 times as high for Aboriginal Australians as for other Australians. 10 One study in Western Australia reporting on AF as the primary outcome, 11 conducted in a hospital inpatient setting, found higher rates in comparison with non-Aboriginal counterparts. A further study of hospital admissions found AF to occur
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in Aboriginal people 15 years earlier than in non-Aboriginal people, as well as higher overall rates in comparison to non-Aboriginal people and higher long-term mortality rates among the Aboriginal patients. 12 However, little data on the prevalence of AF in Australian Aboriginal communities is available.
Given the limited available and inconsistent data on AF, and acknowledged importance as a risk factor for cardiovascular disease, early screening and detection holds promise in improving clinical and population outcomes. Early screening and detection usually occurs in primary health care settings and for Aboriginal people the Aboriginal Community Controlled Health Services (ACCHS) play a pivotal role in delivering health care in urban, regional and remote community settings. A key service performed by ACCHS is adult health checks, which are recommended every two years for Aboriginal adults aged 15-54 years and comprise screening of multiple health variables and risk factors including cardiovascular disease and health promotion. 13 The checks are typically conducted by Aboriginal Health Workers (AHWs) and pathways exist for subsequent referral to relevant health professionals and specialists, although these can be variable depending on location, remoteness and system factors. 14 The feasibility and acceptability of the iECG device to health staff working within the Aboriginal Community Controlled Health sector as a tool for determining AF prevalence among Aboriginal adults is unknown. AF is not only often asymptomatic, 15 but
Aboriginal Australians are more likely to delay accessing the healthcare system until later in a disease process or may not seek timely help in emergencies due to issues such as fear, racism and service access. 16, 17 However, ACCHS can help overcome these barriers and has achieved better health outcomes for Aboriginal people than mainstream services. 17 This study aims to determine the feasibility and acceptability to health staff of opportunistic screening through the use of an iECG device to detect AF among Aboriginal adults within community controlled health settings.
Methods

Study design
The study adopted a mixed methods design and took place during 2017. It was co-designed and implemented with the participating communities and community services. The full protocol of a study to conduct opportunistic screening for AF among Aboriginal adults that included the examination of the feasibility and acceptability of the device has been described elsewhere. 18 
Participants
Interviewees were 18 ACCHS staff (Aboriginal and non-Aboriginal), including AHWs and registered nurses (RNs). They were purposefully sampled from the 11 ACCHS involved in the study due to their specific involvement in the full study as the ACCHS contact personnel and/or had responsibility through their professional role in conducting iECG screening with patients. Participating ACCHS were located in urban (major cities, N=2), regional (N=7) and remote (N=2) areas 19 within New South Wales (NSW; N=7), Western Australia (WA; N=3) and the Northern Territory (N=1). At the commencement of the study, staff received face-to-face training at their ACCHS in the use of the device, consent processes for patients, cardiovascular health promotion and treatment, data collection and the clinical pathway for patients with a non-normal result. The screening process involved using a dedicated smartphone with an iECG device to screen a patient and using the device software to transmit the ECG result to the study database via the telephone data network using an activated sim card. Internet connectivity was required to transmit the results to a secure website for data storage but was not required for the screening itself. Screening occurred from June 2016 to February 2018 and the iECG device was retained by ACCHS at the end of the full study for ongoing use in routine practice. All interviewees provided informed verbal and written consent to take part.
Measures
The study measures were developed in partnership with Aboriginal investigators and communities in each of the three states/ territories that the study was conducted in to ensure their contextual integrity. Face validity of the measures were also determined through this co-design process. Quantitative and qualitative questions identified the enabling factors and barriers for AHWs and other ACCHS staff using the iECG in their roles and Aboriginal patients' receptiveness to the iECG as perceived by the iECG screeners. Semi-structured interviews included seven quantitative fivepoint Likert question items (strongly agree, agree, neither agree nor disagree, disagree, strongly disagree). Staff were asked whether they felt they were provided with sufficient training for the study and their confidence in providing iECG screening, and in managing the pathway and treatment plan for patients who required follow-up. Interviewees were also asked whether they believed patients (who were subsequently diagnosed with AF) followed their treatment plan for the condition, whether the process was beneficial for participants (who were screened) and the time commitment required for the study. Five qualitative open-ended questions asked interviewees what they thought was useful for patients, how patients responded to screening, what interviewees liked and found challenging about the process and any suggestions for improvement (Box 1). Potential participants were able to choose to take part through a group interview if preferred.
Procedure
Data collection occurred during the second half of 2017. Purposefully sampled interviewees in each ACCHS were approached by the researcher coordinating the study by telephone, face-to-face or by email, as appropriate, and invited to participate and/ or suggest other suitable interviewees within the ACCHS. Interviews were conducted at a time and location convenient to the interviewees by one of five researchers (RM, HF, SH, KT, HF) with the exception of two interviews, which were conducted by two researchers following the community's 
Data analyses
For the quantitative questions, the five-level Likert question items were scored from 5=strongly agree to 1=strongly disagree. Mean scores and their standard deviation were calculated in Microsoft Excel. For the qualitative questions, thematic analysis 20 was used to capture key themes around feasibility and acceptability of the device within ACCHS, including perceived barriers and enablers to its use. An inductive approach was used to code the data transcripts and identify frequently occurring themes that emerged from the coded content. Data analyses were conducted and cross-checked by two researchers who had conducted the majority of the interviews. A member-checking 21 process was undertaken through consultation with the Aboriginal investigators and community members to finalise the results and include their correct interpretation.
Results
Information on the geographical location and occupational characteristics of the interviewees as well as the type of interview is presented in Table 1 .
Quantitative data
Mean score and standard deviation of fiveitem Likert scale questions are presented in Table 2 . Overall, interviewees reported they were provided with sufficient training for their role in the screening study and did not believe that the study took too much of their time. They expressed confidence in providing an iECG screening and in managing the referral follow-up pathway for patients where required. Most agreed that the process of screening to detect and manage AF in Aboriginal patients, regardless of the diagnosis, was beneficial for patients although less were convinced that most patients diagnosed with AF would follow their treatment plan.
Qualitative data
Qualitative data outlining four main themes of feasibility; acceptability; use as an educational tool; barriers to use are described with exemplary quotes in Figures 1-4 .
Theme 1: Feasibility of the iECG for ACCHS screening
The majority of interviewees spoke about the usefulness of the device to undertake opportunistic screening in their roles. Specifically, they found the iECG simple, quick and easy to use and liked its portable nature. Question Percent 'agree' or strongly agree' 1. 'I was provided with sufficient training for my role in this study' 88.9% 2. 'I was confident in providing an iECG screening' 100.0% 3. 'I was confident in managing the referral pathway for patients who required a confirmation ECG by the GP' 94.4% 4. 'After a patient was diagnosed with Atrial Fibrillation, I was confident helping support their treatment plan' 94.4% 5. 'I believe most patients followed their treatment plan' 61.1% 6. 'I believe this process of screening to detect and manage AF in Aboriginal patients, regardless of the diagnoses, was beneficial for patients' 83.3% 7. 'I believe that this study took too much of my time ' 16.7%
Several interviewees also thought they could use the device in the future as part of standard adult health checks for Aboriginal patients.
Theme 2: Acceptability of the iECG among staff and patients
Most interviewees described how the device was acceptable for use with patients in their routine practice and enhanced diagnostic and other screening processes for early intervention and chronic disease management. They spoke of how the device was particularly useful beyond clinical settings in the community where it seemed to have greater acceptability among patients and provided more flexible options. This greater acceptability related to comfort and anonymity of community-based screening, with participants indicating how some patients could feel uncomfortable with perceived implications of screening results in the clinical setting. While all interviewees described how the device was generally well received by patients, some interviewees communities, the importance of AHWs in providing culturally-competent care in partnership with other health professionals and their expertise was described, taking account of complexities around community factors. While patients appeared to be most comfortable with AHWs, conflicting cultural issues relating to traditional views regarding the heart, AHW professional authority and caution around heart health and cultural boundaries relating to their professional and personal roles in the community were described by remote AHWs. These issues related to the management of patients and relationships with community members and the interactions of these factors with the roles of non-Aboriginal health professionals whose expertise and lack of cultural conflict could provide clarity for patients and support the initial screening by AHWs.
Theme 3: Use as an educational tool
Several interviewees described how the iECG device provided unique opportunities to engage patients in education around AF and their heart, and to empower patients to find out more about their heart health. Some staff also spoke of how using the device for screening led them to want to learn more about AF and cardiovascular disease themselves in their professional role.
Theme 4: Barriers and enablers to using the device existed
Some challenges or barriers were also described. These were a mixture of cultural and logistical issues, but many of the latter related to the requirements of the study protocol. A number of logistical issues were described across urban, regional and remote communities relating to the internet connectivity required to upload data collected by the device. Interviewees outlined some challenges in ensuring patients could receive appropriate followup within the required time period and that patients returned for follow-up of unclassified or positive readings, particularly when the device was used in the community setting. The consent process and paperwork requirements of the study were also described by interviewees as a barrier to both their and their patients' participation.
Interviewees spoke about how training procedures delivered by the researchers and onsite assistance helped to overcome some of the barriers described. They also highlighted how educational resources would also help overcome barriers around knowledge of AF and the screening process.
Discussion
Our findings demonstrate the feasibility and acceptability of a portable, handheld iECG device for the screening and detection of AF within ACCHS and related community settings across a range of urban, regional and remote areas in Australia.
Several studies have previously established the feasibility and acceptability of a range of screening tools among Aboriginal populations 22, 23 as well as iECG devices in mainstream populations. 5, 7 This study is the first to examine these factors in relation to the iECG screening tool in Aboriginal populations. Our quantitative data found that both Aboriginal and non-Aboriginal ACCHS staff were confident in providing iECG screening and managing the referral follow-up pathway, and felt the process was beneficial for patients. The feasibility and acceptability of screening tools within the ACCHS setting has been described previously 23 and our findings confirm the usefulness of screening in this setting across urban, rural and remote settings. Interviews confirmed the feasibility and usefulness of iECG screening in the community setting despite several barriers. These findings are consistent with the results Our qualitative data also highlighted the usefulness of the device to undertake opportunistic screening and its acceptability in routine practice, specifically in providing an easy-to-use resource to assist cardiac diagnosis that was favoured by patients. These are positive enablers to achieving greater access to, and update of, preventive and treatment services within primary care, known to be linked with better health outcomes. 26 A couple of interviewees suggested incorporating the iECG screening tool into Aboriginal adult health checks, which provide comprehensive health assessments and enable opportunities to provide health advice and risk factor modification. 27 This would align with the interviewee recommendations of the potential for the iECG device to be used as an educational tool for wider health promotion and a component of empowerment through improving health literacy 28 ; we recommend the process of formal addition to adult health checks 13 be investigated further.
Several barriers to screening were described by ACCHS staff. These included a lack of time to complete screening, logistical and technical issues with the device, implementation of the protocol such as a lack of opportunity for timely follow-up with a doctor, and internet connectivity issues. Some of these barriers related only to the study protocol, not the use of the device itself, such as the requirement to upload data to the study and so would not be present in ongoing use or might be overcome with an upgraded smartphone. The 24-hour time period required for follow-up with a doctor was reported as challenging to achieve in remote areas where a doctor may only provide weekly community visits, yet the screening process was considered to have overall benefits in identifying patients potentially at risk of AF to ACCHSs staff that may not otherwise have occurred. Few interviewees reported actual barriers to patient engagement with the device generally positively received. Only a small number of participants, mainly AHWs in remote areas, expressed patient concern, fear and confusion related to the device and its results. Strategies described to overcome these reported barriers included supporting the positive interpersonal relationships that provide trust between AHWs and patients. 29 The barrier related to obtaining participant consent and related research paperwork would not exist outside of the research processes. The protocol for this study 18 stated that the local Aboriginal healthcare workforce would collect the data, however, this was not the case in all participating sites (Table  1 ). This was due to a variety of reasons: AHW availability and role in the clinical setting; hesitancy from a few AHWs to collect the data, requiring more support and time to become confident in the use of the iECG than was feasible for the research team to deliver at the site; cultural issues around privacy; and concern about giving 'bad news' to participants.However, the final study sample gave a broader perspective of the ACCHS screening process including managers as well as AHWs and RNs. Strengths of this study include the examination of a novel device in both a clinic and community setting, the multi-site recruitment of interviewees across three states/territories, urban, regional and remote areas and across a range of professional roles within ACCHS. The study was designed and implemented in close collaboration with communities and community services, an approach vital to achieving culturally relevant acceptance and engagement in cardiac care. 30 While the study participants gave many positive perspectives of the screening, some difficulties were also described such as the difficulty in obtaining consent and ensuring follow-up took place, as well as fear of the device and its results among some people. Overall, we therefore consider the study to give accurate data about the feasibility and acceptability of the device for screening. Our findings summary and suggestions for future use are outlined in Table 3 .
Conclusion
Overall, the iECG device was well accepted within ACCHS and was feasible to use to screen for AF among Aboriginal patients in both clinical and community settings. A number of barriers to screening within these settings were identified, but solutions to overcome these barriers emerged and the use of the device created interest in relevant training and educational resources. Screening through the iECG device is a feasible and acceptable way to look for untreated AF in a community or clinic setting. It has the potential, if widely utilised and followed up, to reduce the unfortunate outcome of stroke that is experienced at a younger age and higher rates by Aboriginal people, and to contribute to improving the health literacy and health of Aboriginal people. 
